INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE is a prominent scholarly journal published by CESKA LEKARSKA SPOLECNOST J EV PURKYNE in the Czech Republic. With an ISSN of 1210-7913, this journal has been at the forefront of research since its inception in 1994, showcasing a rich repository of studies bridging the domains of epidemiology, microbiology, immunology, and infectious diseases, and reflecting advancements over three decades. Although it currently falls within the Q4 category in multiple fields including Epidemiology and Microbiology, the journal serves an essential role in disseminating knowledge and fostering discussions around public health challenges. The contributions made through its pages are vital for researchers, healthcare professionals, and students aiming to enhance their understanding of complex biomedical issues. While it does not offer open access, the journal remains a critical resource in its niches, inviting readers to engage with the latest findings and methodologies reshaping the landscape of health science.

Tropical Diseases Travel Medicine and Vaccines, published by SPRINGERNATURE, stands at the forefront of research in the fields of infectious diseases and public health, with an impressive impact factor that signifies its relevance and influence. Since its inception in 2015, this peer-reviewed journal has maintained an open access policy, ensuring that cutting-edge research on tropical diseases and travel medicine is readily available to researchers, professionals, and students worldwide. The journal currently ranks in the Q2 Quartile for both Infectious Diseases and Public Health, Environmental and Occupational Health, reflecting its substantial contribution to these critical areas of study. With a strong Scopus rank of #176 in Public Health and #138 in Infectious Diseases, it serves as a vital platform for innovative studies that advance understanding and response strategies related to tropical diseases. For its vast audience, Tropical Diseases Travel Medicine and Vaccines not only acts as a bridge connecting researchers with practical applications but also nurtures academic discourse essential for future advancements in global health.

China CDC Weekly is an esteemed academic journal published by the Chinese Center for Disease Control and Prevention, dedicated to disseminating critical research in the fields of epidemiology, infectious diseases, and public health. Since its inception in 2019, the journal has rapidly established itself as a key resource for scholars, professionals, and students, achieving notable rankings, including Q2 in Epidemiology and Infectious Diseases, and Q1 in Public Health, Environmental, and Occupational Health for 2023. With an emphasis on the latest advancements and data-driven insights, China CDC Weekly offers a platform for researchers to contribute to the vital discourse surrounding health policies, disease control, and public safety in a rapidly evolving global landscape. As an open-access journal, it ensures widespread availability and visibility of research findings, reflecting its commitment to advancing public health knowledge in China and beyond. The conference years from 2019 to 2024 further highlight its responsiveness to emerging health challenges and trends, positioning the journal as a preeminent publication for interdisciplinary collaboration and innovation.

Vaccine: X, published by Elsevier, is a premier open access journal dedicated to advancing research in the interdisciplinary fields of immunology and microbiology, infectious diseases, molecular medicine, and public health. With an ISSN of 2590-1362 and operating since 2019, the journal has rapidly established an influential role, achieving Q2 rankings in major categories such as Immunology and Microbiology, Infectious Diseases, and Public Health for 2023. Its commitment to disseminating cutting-edge research is evident from its broad scope, focusing on innovative vaccines and therapies that are critical for global health. Researchers and professionals will find value in the accessible nature of the journal, which has been recognized for its contributions to veterinary medicine as well, with a Q1 ranking in the miscellaneous veterinary category. The journal proudly showcases high-quality, peer-reviewed articles and welcomes submissions that push the boundaries of current knowledge, making it an essential resource for anyone involved in vaccine research and development.

The Lancet, established in 1823, is one of the most prestigious peer-reviewed journals in the field of medicine, published by Elsevier Science Inc. Renowned for its rigorous standards and commitment to high-quality research, this journal occupies a leading position in the academic world, holding an impressive Q1 category ranking in Medicine (miscellaneous) as of 2023, and ranking #1 out of 636 in the general medicine category with a remarkable 99th percentile according to Scopus. With an emphasis on global health, clinical practice, and medical policy, The Lancet aims to disseminate innovative research that pushes the boundaries of medical knowledge and informs practice worldwide. Although it does not currently offer Open Access options, its high impact factor and historical significance make it an essential resource for researchers, healthcare professionals, and students committed to advancing health and medicine. Engaging with this journal ensures staying at the forefront of critical developments in the medical field.

The Journal of Epidemiology and Global Health (ISSN: 2210-6006; E-ISSN: 2210-6014), published by SpringerNature, stands as a premier open-access platform in the field of epidemiology, dedicated to advancing our understanding of global health challenges since 2011. Based in Switzerland, this journal is recognized for its significant contributions to the discipline, achieving an impressive Q1 ranking in Epidemiology and positioning itself at the 88th percentile within the Scopus Medicine - Epidemiology category. With a goal to disseminate innovative research and foster dialogue among scholars, public health professionals, and students, the journal provides a rich repository of empirical studies, reviews, and theoretical contributions that address pressing epidemiological issues. Its commitment to open access ensures that vital research is freely available to the global community, thereby amplifying its impact and relevance. Researchers seeking to publish and access high-quality, peer-reviewed articles will find the Journal of Epidemiology and Global Health an invaluable resource in navigating the ever-evolving landscape of public health.

HIV Medicine is a prestigious journal published by Wiley that stands at the forefront of research in the fields of health policy, infectious diseases, and pharmacology, with a commendable impact factor reflected in its Q1 rankings for 2023. Established in 1999 and set to converge its expertise through 2024, this journal plays a critical role in advancing the understanding and treatment of HIV and related health challenges. It is esteemed for its rigorous peer-review process and its contributions to both clinical and policy-oriented discussions surrounding HIV medicine. With a broad international readership, it serves as a vital resource for researchers, healthcare professionals, and students committed to fighting the global HIV epidemic. Although not open access, its vital insights are indispensable for anyone involved in infectious disease research and healthcare policy. Articles published in HIV Medicine shape global health strategies and influence the future of HIV research, making it a must-read for those dedicated to this crucial field.

JOURNAL OF TROPICAL PEDIATRICS, published by Oxford University Press, stands as a critical platform for the dissemination of research and clinical advancements in the field of tropical pediatrics. With a rich history dating back to 1955, this journal serves as a significant contributor to our understanding of health issues affecting children in tropical and subtropical regions, focusing on infectious diseases, pediatric care, and child health. It currently holds an impressive Q2 ranking in three categories: Infectious Diseases, Medicine (miscellaneous), and Pediatrics, Perinatology and Child Health, placing it among the top journals in its field. Featuring both formative research and applied studies, the journal aims to address the unique challenges posed by pediatric care in tropical environments. Its inclusion in an esteemed database ensures a broad dissemination of critical knowledge to researchers, healthcare professionals, and students alike, promoting a collaborative approach to improving child health outcomes globally.

Tropical Medicine & International Health is a distinguished journal published by Wiley, dedicated to the exploration and dissemination of cutting-edge research in the fields of infectious diseases, parasitology, and public health. With a robust open-access option, the journal facilitates the widespread sharing of information critical to addressing health issues in tropical and international settings. Since its inception in 1996, it has established a significant presence in the academic community, as indicated by its impressive ranking in various Scopus categories, notably positioned in the Q1 quartile for Parasitology and Q2 for both Infectious Diseases and Public Health, reflecting its high influence within these domains. The journal's commitment to advancing knowledge on health challenges prevalent in tropical environments makes it an invaluable resource for researchers, healthcare professionals, and students alike who are dedicated to improving global health outcomes.